期刊文献+

EGFR、Her-2及VEGF在结直肠癌组织中的表达及对患者治疗效果的影响 被引量:1

Expression of EGFR,Her-2,VEGF in colorectal cancer tissues and influence on patient prognosis
原文传递
导出
摘要 目的 检测EGFR、Her-2及VEGF在结直肠癌患者癌组织中的蛋白表达情况,探讨上述因子在结直肠癌患者癌组织的病理表达特征及对患者预后的影响。方法 选取2018年1月至2019年12月期间在河南理工大学第一附属医院(焦作市第二人民医院)施行结直肠癌根治术60例患者的标本资料进行前瞻性研究,采用免疫组化法(PowerVision二步法)检测EGFR、Her-2及VEGF在新鲜结直肠癌组织标本中的表达特征。结果 EGFR、Her-2、VEGF在癌组织中的表达与患者性别、年龄、肿瘤直径及肿瘤位置无相关性,差异不具有统计学意义(P>0.05);而与肿瘤分化程度、淋巴结有无转移、侵袭深度有关,差异具有统计学意义(P<0.05)。结论 EGFR、Her-2及VEGF在结直肠癌患者癌组织中呈高表达状态,与肿瘤的分化程度及TNM分期均有密切关系,并且在结直肠癌病情发展过程中具有协同作用;三者联合检测对患者预后的判断具有重要意义。 Objective To detect the protein expression of ECFR,VEGF and Her-2 in colorectal cancer tissues,investigate the pathological expression characteristics of these factors in colorectal cancer tssues and influence on patient prognosis.Methods Follow the design principles of prospective study summary,60 cases during the period from January 2018 to December 2019 with colorectal cancer and underwent operative treatment were selected;the expression characteristics of EGFR,Her-2 and VECF in fresh colorectal cancer tissue samples were detected.Results There was no significant correlation between the expression of ECFR,Her-2 and VEGF and the gender,age,tumor size and tumor location of the patients(P>0.05);they were correlated to a certain extent about the degree of differentiation,lymph node metastasis and invasion depth of the tumor(P<0.05).Conclusion EGFR,Her-2 and VECF are highly expressed in the cancer tissues of colorectal cancer patients;it is closely related to the degree of tumor differentiation and TNM stage;moreover,it has a synergistic effect in the invasion and metastasis of colorectal cancer;the combined detection of the three is of great significance to the prognosis of patients.
作者 鲁全芝 王刚 乔超锋 王玉文 付刚 杜信冈 乔祖俊 LU Quan-zhi;WANG Gang;QIAO Chao-feng;WANG Yu-wen;FU Gang;DU Xin-gang;QIAO Zu-jun(The Second District of General Surgery,the First Affiliated Hospital of Henan Polytechnic University,the Second Peoples Hospital of Jiaozuo,Jiaozuo,Henan 454000,China)
出处 《医药论坛杂志》 2023年第10期18-22,共5页 Journal of Medical Forum
基金 河南理工大学青年基金资助(Q2018-6)。
关键词 结直肠癌 EGFR HER-2 VEGF 治疗效果 Colorectal cancer ECFR Her-2 VECF Prognosis
  • 相关文献

参考文献2

二级参考文献29

  • 1曾瑄,王鹏,武莎斐,高洁,梁智勇,刘彤华.结直肠癌EGFR和HER2蛋白表达及其基因拷贝数分析[J].中华病理学杂志,2007,36(7):447-452. 被引量:8
  • 2Jemal A,Bray F,Center MM,et al.Global cancer statistics [J].CancerJClin,2011,61(2):69-90.
  • 3Yagihashi A,Asanuma K,Tsuji N,et al.Detection of anti-livin antibody in gastrointestinal cancer patients [ J ].Clin Chem,2003,49(7):1206-1208.
  • 4Vucic,Stennicke HR,Pisabarro MT,et al.ML-IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J].Curr Biol,2000,10(21):1359-1366.
  • 5Sawai H,Yasuda A,Ochi N,et al.Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival [ J ].BMC Gastroenterol,2008,8:56.
  • 6Negri FV,Bozzetti C,Lagrasta CA,et al.PTEN status in advanced eolorectal cancer treated with cetuximab [ J ].Br J Cancer,2010,102(1):162-164.
  • 7Tsigris C, Karayiannakis A J, Zbar A, et al. Clinical significance of serum and urinary c+HER2 levels in colorectal cancer [ J ]. Cancerett, 2002,184(2) :215-222.
  • 8Streckfus C, Bigler L, Dellinger T, eta|. The presence of soluble c-HER2 in saliva and serum among women with breast carcinoma: a preliminary study [ J ]. Clin Cancer Res, 2000,6 ( 6 ) : 2363- 2370.
  • 9Kang SH, Cho J, Ha JS, et al. Evaluation of serum HER-2/neu extracelluar domain in breast cancer patients:correlation with tis- sue HER-2/neu status and clinicopathological factors [ J ]. J Kore- an Surg Soc, 2010,78(5) :271-276.
  • 10Pathmanathan N, Bilous AM. HER2 testing in breast cancer: an overview of current techniques and recent developments [ J ]. Pa- thology, 2012,44(7 ) :587-595.

共引文献27

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部